ENTITY

Oncozenge (ONCOZ SF)

19
Analysis
Health Care • Sweden
OncoZenge AB (publ), a pharmaceutical company, engages in the a development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden. It offers BupiZenge, which is in Phase 3 clinical trials for the treatment of pain in the oral cavity. The company was incorporated in 2020 and is headquartered in Bromma, Sweden.
more
Company Event • 22 Sep 2026 21:30 • Latest

Investing in Life Science 2026

Company Event • 27 Aug 2026 14:00 • Upcoming
Add To Calendar

Q2 2026

Company Event • 26 May 2026 14:00 • Upcoming
Add To Calendar

Q1 2026

Company Event • 17 Mar 2026 18:30

Life Science Conference 2026

Company Event • 17 Aug 2021 08:00

Q2 2021

No more events
x